Loading...

QGN

QGN

QIAGEN NV

(QGEN)

2024 6-K

Show Summary

Summary

Convertible Bonds Offering

29 Aug '25

Quarterly Report

21 Aug '25

Financial Results Adjusted

6 Aug '25

Management Update

27 Jun '25

Quarterly Report

12 May '25

Financial Results Release

8 May '25

Q1 2025 Results

8 Apr '25

Financial Results Report

6 Feb '25

Share Repurchase Plan

16 Jan '25

Shareholder Return Plan

13 Jan '25

Quarterly Report

7 Nov '24

Quarterly Results

7 Nov '24

Accountant Change

7 Nov '24

Convertible Bonds Offering

4 Sep '24

Convertible Bond Offering

3 Sep '24

Quarterly Report Filed

1 Aug '24

Financial Results Update

1 Aug '24

Annual Meeting Notice

1 Aug '24

Capital Markets Day

21 Jun '24

Product Discontinuation

6 Jun '24

Quarterly Report

30 Apr '24

Quarterly Results Report

30 Apr '24

Financial Results Announcement

8 Feb '24

Share Repurchase Plan

22 Jan '24

Shareholder Return Plan

8 Jan '24

External Links:

SEC

On February 6, 2024, QIAGEN N.V. reported its Q4 2023 results, showing net sales of $509 million (+2% YoY) and adjusted diluted EPS of $0.55, surpassing the expected $0.53. Full-year net sales declined to $1.97 billion, but the company anticipates at least $2.0 billion in 2024, driven by 8% growth in non-COVID products.

AI Assistant

QIAGEN NV

2024

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.